|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/11/17 Vivos Inc 10-Q 6/30/17 57:3.9M M2 Compliance/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 281K
2: EX-10.1 Material Contract HTML 120K
3: EX-10.2 Material Contract HTML 161K
4: EX-10.3 Material Contract HTML 158K
5: EX-10.4 Material Contract HTML 155K
6: EX-10.5 Material Contract HTML 114K
7: EX-10.6 Material Contract HTML 222K
8: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
17: R1 Document and Entity Information HTML 37K
18: R2 Condensed Balance Sheets HTML 87K
19: R3 Condensed Balance Sheets (Parenthetical) HTML 36K
20: R4 Condensed Statements of Operations (Unaudited) HTML 69K
21: R5 Condensed Statements of Cash Flow (Unaudited) HTML 101K
22: R6 Basis of Presentation and Significant Accounting HTML 40K
Policies
23: R7 Going Concern HTML 27K
24: R8 Fixed Assets HTML 25K
25: R9 Intangible Assets HTML 25K
26: R10 Related Party Transactions HTML 22K
27: R11 Convertible Notes Payable HTML 40K
28: R12 Common Stock Options and Warrants HTML 59K
29: R13 Stockholders' Equity HTML 21K
30: R14 Supplemental Cash Flow Information HTML 25K
31: R15 Commitments and Contingencies HTML 20K
32: R16 Subsequent Events HTML 22K
33: R17 Basis of Presentation and Significant Accounting HTML 42K
Policies (Policies)
34: R18 Basis of Presentation and Significant Accounting HTML 33K
Policies (Tables)
35: R19 Fixed Assets (Tables) HTML 24K
36: R20 Intangible Assets (Tables) HTML 24K
37: R21 Convertible Notes Payable (Tables) HTML 36K
38: R22 Common Stock Options and Warrants (Tables) HTML 62K
39: R23 Basis of Presentation and Significant Accounting HTML 27K
Policies - Schedule of Fair Value of Financial
Instruments (Details)
40: R24 Going Concern (Details Narrative) HTML 35K
41: R25 Fixed Assets (Details Narrative) HTML 20K
42: R26 Fixed Assets - Schedule of Fixed Assets (Details) HTML 28K
43: R27 Intangible Assets (Details Narrative) HTML 20K
44: R28 Intangible Assets - Schedule of Intangible Assets HTML 26K
(Details)
45: R29 Related Party Transactions (Details Narrative) HTML 32K
46: R30 Convertible Notes Payable (Details Narrative) HTML 65K
47: R31 Convertible Notes Payable - Schedule of HTML 43K
Convertible Notes Payable (Details)
48: R32 Convertible Notes Payable - Schedule of HTML 59K
Convertible Notes Payable (Details)
(Parenthetical)
49: R33 Common Stock Options and Warrants - Schedule HTML 69K
Summarizes Changes in Stock Option (Details)
50: R34 Common Stock Options and Warrants - Schedule HTML 69K
Summarizes Changes in Stock Warrants (Details)
51: R35 Stockholders' Equity (Details Narrative) HTML 44K
52: R36 Supplemental Cash Flow Information (Details HTML 73K
Narrative)
53: R37 Commitments and Contingencies (Details Narrative) HTML 22K
54: R38 Subsequent Events (Details Narrative) HTML 51K
56: XML IDEA XML File -- Filing Summary XML 88K
55: EXCEL IDEA Workbook of Financial Reports XLSX 42K
11: EX-101.INS XBRL Instance -- admd-20170630 XML 691K
13: EX-101.CAL XBRL Calculations -- admd-20170630_cal XML 119K
14: EX-101.DEF XBRL Definitions -- admd-20170630_def XML 332K
15: EX-101.LAB XBRL Labels -- admd-20170630_lab XML 635K
16: EX-101.PRE XBRL Presentations -- admd-20170630_pre XML 481K
12: EX-101.SCH XBRL Schema -- admd-20170630 XSD 112K
57: ZIP XBRL Zipped Folder -- 0001493152-17-008943-xbrl Zip 68K
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the accompanying quarterly report of Advanced Medical Isotope Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2017 (the “Report”), the undersigned, Michael Korenko, Chief Executive Officer of the Company, and L. Bruce Jolliff, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: August 11, 2017 | ||
| By: | /s/ Michael K. Korenko | |
| Name: | Michael K. Korenko | |
| Title: | Chief Executive Officer |
| By: | /s/ L. Bruce Jolliff | |
| Name: | L. Bruce Jolliff | |
| Title: | Chief Financial Officer |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/11/17 | None on these Dates | ||
| For Period end: | 6/30/17 | |||
| List all Filings | ||||